Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gilead Sciences
Gilead Sciences
Gilead Will Keep Hepatitis C Dominance In Its Grip With Recent Trial Results
Seeking Alpha
Tue, 04/28/15 - 08:49 am
Gilead Sciences
Harvoni
hepatitis C
AbbVie
Bristol-Myers Squibb
Merck
Achillion
Analyst: Biogen Will Miss On Tecfidera Sales; No Threat To Gilead's Harvoni
Yahoo/Benzinga
Fri, 04/24/15 - 10:35 am
Biogen
Tecfidera
Merck
Gilead Sciences
grazoprevir/elbasvir
Harvoni
hepatitis C
Gilead to Use a Give-Away Program in Georgia for Reducing Hepatitis C
WSJ Pharmalot
Thu, 04/23/15 - 08:03 pm
Gilead Sciences
hepatitis C
Sovaldi
Mylan's generic Sovaldi launches in India
Medical Marketing and Media
Thu, 04/23/15 - 07:57 pm
Mylan
Sovaldi
India
generics
Gilead Sciences
Merck and Gilead square off in battle of the next-next-gen hep C combos
Fierce Biotech
Thu, 04/23/15 - 09:50 am
Merck
Gilead Sciences
hepatitis C
grazoprevir/elbasvir
GS-5816
GS-9857
Gilead Earnings Preview: What You Should Know
Investopedia
Thu, 04/23/15 - 03:14 am
earnings
Gilead Sciences
Gilead Buying Vertex? What's The Use?
Seeking Alpha
Thu, 04/23/15 - 03:05 am
Gilead Sciences
Vertex Pharmaceuticals
M&A
Gilead Should Buy Vertex Pharma for $45B Now, Analyst Says
TheStreet.com
Tue, 04/21/15 - 09:26 am
Gilead Sciences
Vertex Pharma
M&A
Gilead Sciences: Serious Cash Means An Acquisition Could Be Coming Soon
Seeking Alpha
Mon, 04/20/15 - 05:18 pm
M&A
Gilead Sciences
Morningstar: Gilead Sciences To Grow Its Hepatitis C Market
Yahoo/Morningstar
Sun, 04/19/15 - 11:48 am
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
4 Big Biopharma Deals We Might See In 2015
Seeking Alpha
Fri, 04/17/15 - 08:42 am
AbbVie
AstraZeneca
Biomarin
Bristol-Myers Squibb
Celgene
Gilead Sciences
GSK
Hospira
Jazz Pharmaceuticals
Merck
Seattle Genetics
Shire
Gilead's hep C drugs make it king of the hill in U.S. drug sales
Fierce Pharma
Wed, 04/15/15 - 02:36 pm
Gilead Sciences
Harvoni
Sovaldi
Five companies that may be looking to buy Ariad Pharmaceuticals
Bizjournals.com
Wed, 04/15/15 - 08:44 am
Ariad Pharmaceuticals
M&A
Roche
Celgene
AbbVie
Gilead Sciences
Pfizer
Gilead Sciences Sparks Analyst Dispute Over Hep C Forecasts
TheStreet.com
Tue, 04/14/15 - 10:26 am
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
Why Merck's Victory Is of Little Concern to Gilead
Investopedia
Sat, 04/11/15 - 10:27 am
Merck
Gilead Sciences
grazoprevir/elbasvir
Harvoni
Sovaldi
Gilead: Little Hep C Competition, But What About Pricing?
Barron's
Fri, 04/10/15 - 03:50 pm
Gilead Sciences
Merck
AbbVie
hepatitis C
Gilead's Little Tweak Could Produce Big Revenue
Investopedia
Thu, 04/9/15 - 09:42 am
Gilead Sciences
HIV
Viread
TAF
Latest Merck, AbbVie Data Not A Threat To Gilead: Citi
Barron's
Wed, 04/8/15 - 12:05 pm
Merck
AbbVie
hepatitis C
Gilead Sciences
grazoprevir/elbasvir
Harvoni
Gilead's low-dose, high-impact HIV drug heads to the FDA
Bizjournals.com
Wed, 04/8/15 - 10:17 am
Gilead Sciences
HIV
FDA
tenofovir
emtricitabine
Gilead's CEO John Martin: Worth The Money?
Seeking Alpha
Mon, 04/6/15 - 06:08 pm
Gilead Sciences
John Martin
executive pay
Pages
« first
‹ previous
…
61
62
63
64
65
66
67
68
69
…
next ›
last »